comparemela.com
Latest Breaking News On - Dermavant sciences gmbh - Page 1 : comparemela.com
Torii Pharmaceutical : Positive Top line Results of Phase 3 Clinical Study (Comparative Study) of JTE 061 (tapinarof) Cream, Aryl hydrocarbon Receptor (AhR) agonist, in Pediatric Patients with Atopic Dermatitis in Japan
FOR IMMEDIATE RELEASE Tokyo, May 31, 2024 Positive Top-line Results of Phase 3 Clinical Study of JTE-061 Cream, Aryl hydrocarbon Receptor .
Tokyo
Japan
Japan-tobacco-inc
Dermavant-sciences-gmbh
Torii-pharmaceutical-co-ltd
Top-line-results
Comparative-study
Pediatric-patients
Atopic-dermatitis
Eczema-area
Severity-index
vimarsana © 2020. All Rights Reserved.